Christopher Bowden
2021
Compensation breakdown
Non-Equity Incentive Plan | $262,621 |
---|---|
Option Awards | $1,404,373 |
Salary | $475,210 |
Stock Awards | $623,480 |
Other | $9,205 |
Total | $2,774,889 |
Bowden received $1.4M in option awards, accounting for 51% of the total pay in 2021.
Bowden also received $262.6K in non-equity incentive plan, $475.2K in salary, $623.5K in stock awards and $9.2K in other compensation.
Rankings
In 2021, Christopher Bowden's compensation ranked 4,733rd out of 12,412 executives tracked by ExecPay. In other words, Bowden earned more than 61.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,733 | 62nd |
Manufacturing | 1,968 | 64th |
Chemicals And Allied Products | 827 | 65th |
Drugs | 740 | 65th |
Pharmaceutical Preparations | 528 | 66th |
Pay ratio
Christopher Bowden's Pay | $2,774,889 |
---|---|
Median Employee's Pay | $315,091 |
Pay Ratio | 9to 1 |
In 2021, the annual total compensation of Christopher Bowden was $2,774,889.
The annual total compensation of the median employee at Agios Pharmaceuticals was $315,091.
The ratio of Christopher Bowden's pay to the pay of median employee was therefore 9 to one.
Bowden's colleagues
We found six more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2021.
2021
Jacqualyn Fouse
Agios Pharmaceuticals
Chief Executive Officer
2021
Jonathan Biller
Agios Pharmaceuticals
Chief Financial Officer
2021
Bruce Car
Agios Pharmaceuticals
Chief Scientific Officer
2021
Darrin Miles
Agios Pharmaceuticals
Former Chief Commercial Officer
2021
Sarah Gheuens
Agios Pharmaceuticals
Chief Medical Officer
2021
Richa Poddar
Agios Pharmaceuticals
Chief Commercial Officer
News
April 28, 2022
April 8, 2021
April 16, 2020
April 18, 2019